Tag

Medicines And Healthcare Products Regulatory Agency

All articles tagged with #medicines and healthcare products regulatory agency

MHRA flags over 150 deaths linked to weight-loss drugs as adverse reports surge
health3 hours ago

MHRA flags over 150 deaths linked to weight-loss drugs as adverse reports surge

The MHRA reports more than 150 deaths linked to GLP-1 weight-loss drugs, based on around 150,000 adverse-reaction reports. Tirzepatide (Mounjaro) accounts for the majority of serious reports and near-100 fatalities; semaglutide (Wegovy) and liraglutide (Saxenda) also appear in the data. Regulators caution that reports do not prove causation and that benefits of GLP-1 medicines generally outweigh risks when used under medical supervision; manufacturers stress ongoing safety monitoring.

Beware of Fake Weight Loss Jabs: Brits Hospitalized
health2 years ago

Beware of Fake Weight Loss Jabs: Brits Hospitalized

Health officials in the UK have issued an urgent safety alert after fake weight loss jabs, specifically counterfeit Ozempic pens, were found on the black market. The Medicines and Healthcare products Regulatory Agency has seized 369 counterfeit pens since January, with some individuals being hospitalized and left in comas after using them. The agency warns against purchasing pre-filled weight loss pens without a prescription, as they do not meet safety standards and pose significant health risks. Authorities are urging the public to report any suspicious products and cracking down on illegal online suppliers.

Northwest Biotherapeutics' Near Term Plans for Marketing Authorization Application Submission
biotechnology2 years ago

Northwest Biotherapeutics' Near Term Plans for Marketing Authorization Application Submission

Northwest Biotherapeutics is providing an update on its progress towards submitting a Marketing Authorization Application (MAA) to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK for its DCVax-L treatment for glioblastoma. The majority of the MAA has been completed, with only one key section remaining. The company plans to submit applications to multiple regulators and is taking additional time to ensure the MAA package is strong. The remaining section is expected to be delivered to the publisher within two weeks, with the MAA submission anticipated to take place between mid and late November.